A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...